Quanterix Corporation Overview
Pro stress-test →Quanterix is a life sciences company that develops and markets digital immunoassay platforms advancing precision health for life sciences research and diagnostics across North America, Europe, Middle East, Africa, and Asia Pacific regions. The company develops ultra-sensitive detection systems for use in research and in-vitro diagnostics.
Strategic Profile
Pro stress-test →The company operates a consumable-based revenue model providing recurring revenue and high margins as the installed base of Simoa instruments grows. The company primarily operates in neurology, oncology, immunology, and inflammation, with focus on selling to academic/governmental research institutions, pharmaceutical, biotechnology, and contract research companies through direct sales and distributors.
Competitive Landscape
Pro stress-test →According to 3 analysts, the average rating for QTRX is "Hold" with 12-month stock price target of $10.33 representing 35.74% upside from latest price. Quanterix competes in the biomarker diagnostics and ultra-sensitive detection space against established in-vitro diagnostics companies and emerging precision health platforms.
Industry Context
Quanterix Corporation operates in Life Sciences / In-Vitro Diagnostics / Biomarker Detection Technology.
Key facts
Founded: 2007 · Headquarters: Billerica, Massachusetts, US · Revenue: $137.4M (2024) · Market cap: $0.22B